Medical Devices Today

FDA Outlines Next Steps For Online Repository And Standard Elements For Device Labeling

Article preview from "The Gray Sheet" - May 6, 2013

Industry representatives, health care providers, patients and caregivers gathered April 29-30 to discuss CDRH labeling activities and the agency’s ideas for the future.

TearScience Secures $70 Million For One-Of-A-Kind Eye Device

Article preview from Start-Up - March, 2013

TearScience Inc. is ready to go into full-scale commercialization for a new device treatment for the most prevalent form of dry eye. In late February, the young company secured up to $70 million from HealthCare Royalty Partners to help make that happen.

Hologic Buys Interlace Medical, Acquires Missing Link In Gynecology Surgery

Article preview from IN VIVO - January, 2011

Gynecologists generally have the opportunity to perform in-office procedures for three indications: abnormal uterine bleeding, permanent contraception and uterine fibroids. Hologic had supplied its 460 medical device reps in the US - the largest force in women's health - with the tools to perform two of these procedures, but couldn't offer the third piece of the puzzle, an in-office treatment for fibroids, a gap which, until now, hasn't been filled by any product on the market. Hologic is filling in the missing piece with the acquisition of privately held Interlace Medical, a start-up developing MyoSure, a minimally invasive resection device for submucosal fibroids.